This is the authors' abstract. We don't add key points for this paper.
Particulate embolic agents with calibrated sizes, which employ interventional procedures to achieve endovascular embolization, have recently attracted tremendous interest in therapeutic embolotherapies for a wide plethora of diseases. However, the particulate shape effect, which may play a critical role in embolization performances, has been rarely investigated. Here, polyvinyl alcohol (PVA)‐based shape‐anisotropic microembolics are developed using a facile droplet‐based microfluidic fabrication method via heat‐accelerated PVA‐glutaraldehyde crosslinking reaction at a mild temperature of 38 °C. Precise geometrical controls of the microembolics are achieved with a nearly capsule shape through regulating surfactant concentration and flow rate ratio between dispersed phase and continuous phase in the microfluidics. Two specific models are employed, i.e., in vitro decellularized rabbit liver embolization model and in vivo rabbit ear embolization model, to systematically evaluate the embolization behaviors of the nonspherical microembolics. Compared to microspheres of the same volume, the elongated microembolics demonstrated advantageous endovascular navigation capability, penetration depth and embolization stability due to their comparatively smaller radial diameter and their central cylindrical part providing larger contact area with distal vessels. Such nonspherical microembolics present a promising platform to apply shape anisotropy to achieve distinctive therapeutic effects for endovascular treatments.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: